NORTHWEST BIOTHERAPEUTICS INC Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Northwest Biotherapeutics Inc quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Northwest Biotherapeutics Inc Return On Assets for the quarter ending June 30, 2024 was -254 %, a 9% increase year-over-year.
  • Northwest Biotherapeutics Inc annual Return On Assets for 2023 was -208 %, a 40.4% increase from 2022.
  • Northwest Biotherapeutics Inc annual Return On Assets for 2022 was -348 %, a 163% decline from 2021.
  • Northwest Biotherapeutics Inc annual Return On Assets for 2021 was 553 %.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -208 +141 +40.4% Jan 1, 2023 Dec 31, 2023
2022 -348 -901 -163% Jan 1, 2022 Dec 31, 2022
2021 553 +3.07K Jan 1, 2021 Dec 31, 2021
2020 -2.52K -2.38K -1713% Jan 1, 2020 Dec 31, 2020
2019 -139 -54.2 -64.1% Jan 1, 2019 Dec 31, 2019
2018 -84.6 +66 +43.8% Jan 1, 2018 Dec 31, 2018
2017 -151 -1.78 -1.2% Jan 1, 2017 Dec 31, 2017
2016 -149 +45.6 +23.5% Jan 1, 2016 Dec 31, 2016
2015 -194 +295 +60.3% Jan 1, 2015 Dec 31, 2015
2014 -489 +407 +45.4% Jan 1, 2014 Dec 31, 2014
2013 -896 +2.02K +69.3% Jan 1, 2013 Dec 31, 2013
2012 -2.91K Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.